212 related articles for article (PubMed ID: 12587002)
1. Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults.
Velasquez-Mieyer PA; Cowan PA; Arheart KL; Buffington CK; Spencer KA; Connelly BE; Cowan GW; Lustig RH
Int J Obes Relat Metab Disord; 2003 Feb; 27(2):219-26. PubMed ID: 12587002
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
Lustig RH; Greenway F; Velasquez-Mieyer P; Heimburger D; Schumacher D; Smith D; Smith W; Soler N; Warsi G; Berg W; Maloney J; Benedetto J; Zhu W; Hohneker J
Int J Obes (Lond); 2006 Feb; 30(2):331-41. PubMed ID: 16158082
[TBL] [Abstract][Full Text] [Related]
3. Obesity, leptin resistance, and the effects of insulin reduction.
Lustig RH; Sen S; Soberman JE; Velasquez-Mieyer PA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1344-8. PubMed ID: 15314628
[TBL] [Abstract][Full Text] [Related]
4. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
5. Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.
Lustig RH; Mietus-Snyder ML; Bacchetti P; Lazar AA; Velasquez-Mieyer PA; Christensen ML
J Pediatr; 2006 Jan; 148(1):23-9. PubMed ID: 16423593
[TBL] [Abstract][Full Text] [Related]
6. The relationship between pretreatment dietary composition and weight loss during a randomised trial of different diet approaches.
McVay MA; Jeffreys AS; King HA; Olsen MK; Voils CI; Yancy WS
J Hum Nutr Diet; 2015 Feb; 28 Suppl 2():16-23. PubMed ID: 24251378
[TBL] [Abstract][Full Text] [Related]
7. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.
Lustig RH; Hinds PS; Ringwald-Smith K; Christensen RK; Kaste SC; Schreiber RE; Rai SN; Lensing SY; Wu S; Xiong X
J Clin Endocrinol Metab; 2003 Jun; 88(6):2586-92. PubMed ID: 12788859
[TBL] [Abstract][Full Text] [Related]
8. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
[TBL] [Abstract][Full Text] [Related]
9. Impact of high-protein diets with either moderate or low carbohydrate on weight loss, body composition, blood pressure and glucose tolerance in rats.
Lobley GE; Bremner DM; Holtrop G; Johnstone AM; Maloney C
Br J Nutr; 2007 Jun; 97(6):1099-108. PubMed ID: 17397561
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of a very low-carbohydrate weight loss diet on exercise capacity and tolerance in overweight and obese adults.
Wycherley TP; Buckley JD; Noakes M; Clifton PM; Brinkworth GD
J Am Coll Nutr; 2014; 33(4):267-73. PubMed ID: 24988413
[TBL] [Abstract][Full Text] [Related]
11. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
Due A; Flint A; Eriksen G; Møller B; Raben A; Hansen JB; Astrup A
Diabetes Obes Metab; 2007 Jul; 9(4):566-74. PubMed ID: 17587399
[TBL] [Abstract][Full Text] [Related]
12. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
13. Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults.
Velasquez-Mieyer PA; Umpierrez GE; Lustig RH; Cashion AK; Cowan PA; Christensen M; Spencer KA; Burghen GA
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):330-3. PubMed ID: 14708034
[TBL] [Abstract][Full Text] [Related]
14. Association of late-night carbohydrate intake with glucose tolerance among pregnant African American women.
Chandler-Laney PC; Schneider CR; Gower BA; Granger WM; Mancuso MS; Biggio JR
Matern Child Nutr; 2016 Oct; 12(4):688-98. PubMed ID: 25786515
[TBL] [Abstract][Full Text] [Related]
15. [Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively].
Escobar L; Freire JM; Girón JA; Vázquez JM; Pajares M; Ortego J; Gavilán I; Chover AJ; Carrasco M; Epinosa R; Marín F; Aguilar M
Rev Esp Med Nucl; 2000 Jun; 19(3):199-206. PubMed ID: 11062083
[TBL] [Abstract][Full Text] [Related]
16. Serotoninergic drug-induced weight loss in carbohydrate craving obese patients.
Toornvliet AC; Pijl H; Hopman E; Elte-de Wever BM; Meinders AE
Int J Obes Relat Metab Disord; 1996 Oct; 20(10):917-20. PubMed ID: 8910095
[TBL] [Abstract][Full Text] [Related]
17. The influence of nighttime feeding of carbohydrate or protein combined with exercise training on appetite and cardiometabolic risk in young obese women.
Ormsbee MJ; Kinsey AW; Eddy WR; Madzima TA; Arciero PJ; Figueroa A; Panton LB
Appl Physiol Nutr Metab; 2015 Jan; 40(1):37-45. PubMed ID: 25409324
[TBL] [Abstract][Full Text] [Related]
18. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference.
Magni P; Liuzzi A; Ruscica M; Dozio E; Ferrario S; Bussi I; Minocci A; Castagna A; Motta M; Savia G
Clin Endocrinol (Oxf); 2005 Feb; 62(2):189-96. PubMed ID: 15670195
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women.
Ryan AS; Nicklas BJ; Berman DM; Elahi D
Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1066-71. PubMed ID: 12917712
[TBL] [Abstract][Full Text] [Related]
20. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
